MARKET

IMRN

IMRN

Immuron
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.12
-0.05
-0.61%
After Hours: 8.10 -0.02 -0.25% 17:37 09/18 EDT
OPEN
8.03
PREV CLOSE
8.17
HIGH
8.25
LOW
7.84
VOLUME
40.37K
TURNOVER
--
52 WEEK HIGH
28.99
52 WEEK LOW
1.550
MARKET CAP
45.26M
P/E (TTM)
-17.6791
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average IMRN stock price target is 6.02 with a high estimate of 6.02 and a low estimate of 6.02.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About IMRN
Immuron Limited is a biopharmaceutical company. The Company focuses on the research and development of bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infections and immune modulated diseases. The Company has three segments: Research and Development (R&D), HyperImmune Products and Corporate. The R&D segment focuses on the Company's research and development projects performed in Australia and Israel. The Company sells and licenses its product, Travelan. The HyperImmune Products segment is engaged in its Travelan product's activities, which occur in Australia, New Zealand and Canada. The Corporate segment's activities primarily occur in Australia. It also develops products for applications, including non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH) and clostridium difficile (C-Diff), diabetes, colitis and uropathogenic escherichia coli (UPEC). The Company also offers Protectyn, IMM 124-E-NASH and IMM 529-CDI.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Immuron Limited stock information, including NASDAQ:IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.